title: Pial microcirculation in subarachnoid hemorrhage.
abstract: Microsurgical and microscopic methods were employed in guinea pigs to expose, observe, and measure response characteristics of cerebral cortical pial microvessels and microcirculation to traumatic and nontraumatic experimental subarachnoid hemorrhage. Bleeding produced by vascular micropuncture was associated with a 44.3% arteriolar constriction. Topical application of homologous blood alone produced a 33.2% vasoconstriction. Observed microcirculatory flow characteristics subsequent to such microvascular changes were consistent with those known to be associated with cerebral cortical infarction. These changes could be prevented or reversed by topical application of the alpha adrenergic blocker, phenoxybenzamine. Topical pretreatment with the beta adrenergic blocker, propranolol, prevented blood-induced spasm, but did not reverse such spasm once it had been established. A chemo-mechanical mechanism is suggested as underlying the vasoconstriction association with rupture of pial microvessels. It is thought that consideration of such microvascular characteristics, in conjunction with those known to be associated with larger intracranial vessels, adds to current knowledge of the pathophysiology of subarachnoid hemorrhage and may be extrapolated to bear future clinical import.
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000818:Animals; D001777:Blood Coagulation; D002415:Cats; D002540:Cerebral Cortex / Q000098:blood supply; D002648:Child; D006259:Craniocerebral Trauma; D004195:Disease Models, Animal; D006168:Guinea Pigs; D006493:Heparin / Q000097:blood / Q000494:pharmacology; D006801:Humans; D002546:Ischemic Attack, Transient / Q000503:physiopathology; D008833:Microcirculation / Q000000981:diagnostic imaging / Q000187:drug effects / Q000503:physiopathology*; D010841:Pia Mater / Q000098:blood supply*; D011859:Radiography; D013345:Subarachnoid Hemorrhage / Q000188:drug therapy / Q000503:physiopathology*
chemical_list: D000319:Adrenergic beta-Antagonists; D006493:Heparin